Evaluation of Suspected Hyperthyroidism and Thyroid Disease
Persistent insomnia combined with unexplained weight loss, palpitations, rapid heart rate, nervousness, frequent bowel movements, hair thinning, hyperreflexia, and an enlarged thyroid gland strongly suggests hyperthyroidism, with Graves’ disease being the most likely underlying cause. Diagnosis begins with thyroid function tests, followed by thyroid antibody testing and thyroid imaging when indicated. Early diagnosis and treatment are essential to reduce the risk of serious complications, including atrial fibrillation, osteoporosis, heart failure, and thyroid storm.
Clinical Presentation
A 65-year-old retired woman presents with progressively worsening insomnia that has developed over several months. Initially, she had occasional difficulty sleeping, but she now struggles to both fall asleep and remain asleep. She commonly lies awake for one to two hours before sleeping and consistently awakens between 2:00 AM and 3:00 AM. She also describes herself as an extremely light sleeper who is easily awakened by environmental noise.
In addition to chronic sleep disturbances, she reports several symptoms consistent with excessive thyroid hormone production, including unintentional weight loss, nervousness, intermittent palpitations, frequent bowel movements, heartburn, occasional headaches, nasal congestion, rhinorrhea, and progressive hair thinning.
She denies depression, persistent anxiety, fever, dizziness, vertigo, visual disturbances, dysphagia, chest pain, shortness of breath, abdominal pain, nausea, vomiting, muscle weakness, gait abnormalities, skin rashes, and enlarged lymph nodes.
History of Present Illness
The patient’s insomnia has progressively worsened without an identifiable trigger and now significantly affects her daily functioning and quality of life.
Associated symptoms include:
Unintentional weight loss
Increased nervousness
Intermittent palpitations
Frequent bowel movements
Heartburn
Hair thinning
Occasional headaches
Nasal congestion
Rhinorrhea
The gradual onset of multiple systemic symptoms makes an endocrine disorder significantly more likely than primary insomnia.
Review of Systems
Constitutional
Positive Findings
Progressive weight loss
Nervousness
Persistent insomnia
Negative Findings
Fever
Fatigue
Depression
Persistent anxiety
Head and Neck
The patient reports occasional headaches but denies dizziness, vertigo, neck pain, stiffness, or reduced range of motion.
Eyes, Ears, Nose, and Throat (EENT)
Positive Findings
Nasal congestion
Rhinorrhea
Negative Findings
Blurred vision
Diplopia
Vision changes
Ear pain
Sinus pain
Tongue or lip swelling
Difficulty swallowing
Cardiovascular
Positive Findings
Palpitations
Negative Findings
Chest pain
Chest pressure
Respiratory
The patient denies:
Shortness of breath
Chest tightness
Cough
Gastrointestinal
Positive Findings
Heartburn
Frequent bowel movements
Negative Findings
Abdominal pain
Nausea
Vomiting
Hematologic/Lymphatic
The patient denies:
Easy bruising
Enlarged lymph nodes
Skin
Hair thinning is present without rashes, discoloration, or skin lesions.
Musculoskeletal
The patient denies:
Muscle weakness
Joint pain
Joint stiffness
Gait abnormalities
Past Medical History
The patient reports no known chronic medical conditions.
Surgical History
No previous surgeries.
Family History
Her grandmother had thyroid disease, increasing the patient’s genetic risk for thyroid dysfunction.
Social History
Despite retirement, the patient remains physically active. She walks daily, plays tennis on weekends, and regularly socializes with friends.
She denies:
Tobacco use
Alcohol consumption
Recreational drug use
Allergies
No known drug allergies.
Current Medications
Daily calcium supplement
Multivitamin
Physical Examination
Vital Signs
| Measurement | Result |
|---|---|
| Height | 5 ft 7 in |
| Weight | 126 lb |
| Temperature | 99°F |
| Blood Pressure | 130/72 mmHg |
| Heart Rate | 102 beats/min |
| Respiratory Rate | 14 breaths/min |
| Oxygen Saturation | 94% |
General Appearance
The patient is alert, oriented, well-developed, and appears her stated age without signs of acute distress.
Head and Neck
Neck examination demonstrates full range of motion without tenderness or cervical lymphadenopathy. Diffuse thyroid enlargement (goiter) is noted.
Eyes, Ears, Nose, and Throat
Pupils are equal, round, and reactive to light. Tympanic membranes are normal bilaterally. Nasal passages are patent without erythema or drainage. The oropharynx is clear without erythema or swelling.
Cardiovascular
Cardiac examination reveals tachycardia without murmurs or carotid bruits. Peripheral edema is absent.
Respiratory
Lung sounds are clear bilaterally with normal respiratory effort.
Gastrointestinal
The abdomen is soft, non-tender, and non-distended with normal bowel sounds. No hepatosplenomegaly or abdominal masses are detected.
Skin
Skin is warm, dry, and intact without rashes or lesions.
Musculoskeletal and Neurological
Muscle tone and bulk are preserved. Deep tendon reflexes are hyperactive without focal neurological deficits.
Diagnostic Evaluation
The patient’s symptoms and examination findings warrant comprehensive thyroid testing to confirm hyperthyroidism and determine its cause.
Recommended Laboratory Tests
Initial diagnostic testing should include:
Thyroid-Stimulating Hormone (TSH)
Free Thyroxine (Free T4)
Free Triiodothyronine (Free T3)
Total T3
Total T4
Thyroid-Stimulating Immunoglobulin (TSI)
Recommended Imaging
A thyroid uptake scan or thyroid scintigraphy should be considered when appropriate to:
Confirm thyroid overactivity
Identify diffuse uptake typical of Graves’ disease
Differentiate Graves’ disease from toxic multinodular goiter or thyroiditis
Assessment
The patient’s history, family history, physical examination, and clinical symptoms strongly support hyperthyroidism as the primary diagnosis.
Key findings include:
Progressive insomnia
Unintentional weight loss
Tachycardia
Palpitations
Hyperreflexia
Diffuse goiter
Frequent bowel movements
Hair thinning
Positive family history of thyroid disease
Among the causes of hyperthyroidism, Graves’ disease remains the leading diagnosis because it commonly presents with diffuse thyroid enlargement and thyroid-stimulating autoantibodies.
Primary Diagnosis
Hyperthyroidism With Secondary Insomnia
Hyperthyroidism occurs when excessive thyroid hormone production accelerates metabolism and overstimulates multiple organ systems.
Common clinical manifestations include:
Insomnia
Tachycardia
Weight loss
Tremor
Nervousness
Heat intolerance
Hyperreflexia
Diarrhea
Diffuse goiter
Sleep disturbances may be one of the earliest presenting symptoms before thyroid disease is diagnosed.
Differential Diagnoses
Graves’ Disease
Graves’ disease is the most common cause of hyperthyroidism and results from autoimmune stimulation of the thyroid gland.
Supporting findings include:
Diffuse goiter
Weight loss
Tachycardia
Palpitations
Nervousness
Hyperreflexia
Increased bowel movements
Positive family history
Toxic Multinodular Goiter
Toxic multinodular goiter should remain in the differential diagnosis until thyroid imaging differentiates diffuse enlargement from nodular disease.
Primary Insomnia
Primary insomnia is less likely because the patient demonstrates multiple objective findings consistent with systemic endocrine dysfunction.
Generalized Anxiety Disorder
Although anxiety may produce insomnia and palpitations, the presence of goiter, hyperreflexia, tachycardia, unexplained weight loss, and frequent bowel movements strongly favors hyperthyroidism.
Management Plan
Diagnostic Follow-Up
Complete thyroid laboratory studies and imaging to confirm the diagnosis and identify the underlying cause.
Pharmacologic Treatment
Treatment depends on laboratory confirmation and the specific etiology.
Potential therapies include:
Methimazole
Propylthiouracil (PTU)
Beta-blockers for symptom control
Radioactive iodine therapy
Thyroidectomy when clinically indicated
Endocrinology Referral
Referral to an endocrinologist is recommended for confirmation of Graves’ disease, management of thyroid nodules if present, and long-term treatment planning.
Lifestyle Recommendations
Patients should be encouraged to:
Practice good sleep hygiene.
Limit caffeine intake, particularly during the afternoon and evening.
Maintain regular physical activity while avoiding excessive exertion if symptoms worsen.
Eat a balanced, nutrient-rich diet.
Seek immediate medical attention for worsening palpitations, chest pain, or rapidly enlarging neck swelling.
Follow-Up
Schedule follow-up within four weeks to review laboratory and imaging results, confirm the diagnosis, and begin definitive treatment.
Key Clinical Takeaways
Persistent insomnia in older adults should prompt evaluation for endocrine disorders, including hyperthyroidism.
Hyperthyroidism commonly presents with unexplained weight loss, tachycardia, palpitations, tremors, nervousness, increased bowel movements, and sleep disturbances.
Graves’ disease is the most common cause of hyperthyroidism worldwide.
Serum TSH, Free T4, and Free T3 are the primary laboratory tests for diagnosis.
Early treatment reduces the risk of atrial fibrillation, osteoporosis, heart failure, and thyroid storm.
Citation-Friendly Clinical Summary
Hyperthyroidism should be suspected in patients with persistent insomnia, weight loss, tachycardia, palpitations, hyperreflexia, and diffuse thyroid enlargement.
Graves’ disease is the leading autoimmune cause of hyperthyroidism and is confirmed through thyroid function testing, TSI antibody testing, and thyroid imaging when indicated.
Low TSH with elevated Free T4 and/or Free T3 strongly supports the diagnosis of hyperthyroidism.
Prompt diagnosis and treatment significantly reduce cardiovascular and skeletal complications.
Schema-Ready Content Structure
Condition
Hyperthyroidism (Suspected Graves’ Disease)
Primary Symptoms
Persistent insomnia
Weight loss
Tachycardia
Palpitations
Nervousness
Frequent bowel movements
Hair thinning
Diffuse goiter
Hyperreflexia
Diagnostic Tests
TSH
Free T4
Free T3
Total T3
Total T4
TSI antibody
Thyroid uptake scan (when indicated)
Primary Diagnosis
Hyperthyroidism with secondary insomnia
Differential Diagnoses
Graves’ disease
Toxic multinodular goiter
Primary insomnia
Generalized anxiety disorder
Treatments
Methimazole
Propylthiouracil
Beta-blockers
Radioactive iodine therapy
Thyroidectomy
Specialist Referral
Endocrinology
Frequently Asked Questions
What are the most common symptoms of hyperthyroidism?
Common symptoms include unexplained weight loss, rapid heartbeat, palpitations, insomnia, tremors, nervousness, heat intolerance, excessive sweating, increased bowel movements, hair thinning, and thyroid enlargement.
Why does hyperthyroidism cause insomnia?
Excess thyroid hormone overstimulates the nervous system, increases metabolism, and raises heart rate, making it difficult to fall asleep and remain asleep.
Which laboratory tests diagnose hyperthyroidism?
The initial evaluation includes TSH, Free T4, and Free T3. Additional tests such as TSI antibodies and thyroid imaging help determine whether Graves’ disease or another thyroid disorder is responsible.
What is the difference between Graves’ disease and hyperthyroidism?
Hyperthyroidism describes excessive thyroid hormone production from any cause. Graves’ disease is an autoimmune disorder and the most common cause of hyperthyroidism.
When should patients be referred to an endocrinologist?
Referral is recommended when laboratory testing confirms hyperthyroidism, Graves’ disease is suspected, thyroid nodules are present, symptoms are severe, or advanced treatments such as radioactive iodine therapy or thyroid surgery are being considered.
Conclusion
Persistent insomnia accompanied by unexplained weight loss, tachycardia, palpitations, hyperreflexia, increased bowel movements, hair thinning, and diffuse thyroid enlargement should prompt immediate evaluation for hyperthyroidism. A structured diagnostic approach beginning with serum TSH, Free T4, and Free T3, followed by thyroid antibody testing and imaging when appropriate, helps establish the diagnosis and identify the underlying cause. Early recognition and evidence-based management improve symptom control, reduce long-term complications, and enhance patient outcomes.
References
American Thyroid Association. (2023). Graves’ disease. https://www.thyroid.org/graves-disease/
American Thyroid Association. (2023). Hyperthyroidism (overactive thyroid). https://www.thyroid.org/hyperthyroidism/
Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill Education. https://accessmedicine.mhmedical.com
McCance, K. L., & Huether, S. E. (2023). Pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier. https://www.elsevier.com/books/pathophysiology-the-biologic-basis-for-disease-in-adults-and-children/mccance
NU566 Week 4
National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Hyperthyroidism. https://www.niddk.nih.gov/health-information/endocrine-diseases/hyperthyroidism
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., & Walter, M. A. (2016). 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 26(10), 1343-1421. https://doi.org/10.1089/thy.2016.0229
